Related Experiment Video
Updated: Jun 28, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
Catheter-related mortality among ESRD patients
1Division of Nephrology, Department of Medicine, Emory University, Atlanta, Georgia 30322, USA. hwasse@emory.edu
Insights
Central venous catheters (CVCs) pose the highest mortality risk for hemodialysis patients. Arteriovenous fistulas (AVFs) offer better outcomes, lower infection rates, and improved quality of life, making them the preferred access method.
Area of Science:
- Nephrology
- Vascular Surgery
Background:
- Hemodialysis access complications cause significant morbidity and costs in end-stage renal disease patients.
- Effective vascular access is crucial for safe and adequate hemodialysis.
- Central venous catheters (CVCs) are linked to higher infection and mortality rates compared to other access types.
Purpose of the Study:
- To highlight catheter-related mortality in hemodialysis.
- To advocate for increased awareness of catheter-related complications.
- To emphasize the benefits of arteriovenous fistulas (AVFs) over CVCs and synthetic grafts (AVGs).
Main Methods:
- Review of existing literature on hemodialysis vascular access types.
- Analysis of complication and mortality data associated with different access methods (CVC, AVF, AVG).
- Examination of clinical practice guidelines regarding vascular access selection.
Main Results:
- Central venous catheters (CVCs) demonstrate the highest risk of infection-related and all-cause mortality.
- Autogenous arteriovenous fistulas (AVFs) exhibit the lowest infection risk, superior patency, better quality of life, and reduced mortality.
- Synthetic grafts (AVGs) present intermediate risks compared to AVFs and CVCs.
Conclusions:
- The AVF is the optimal vascular access for hemodialysis due to its favorable safety and efficacy profile.
- National Kidney Foundation guidelines recommend early AVF placement for at least 50% of incident hemodialysis patients.
- Heightened awareness and management of CVC-related complications are essential to reduce patient mortality.
Abstract:
Hemodialysis access-related complications remain one of the most important sources of morbidity and cost among persons with end-stage renal disease, with total annual costs exceeding $1 billion annually. In this context, the creation and maintenance of an effective hemodialysis vascular access is essential for safe and adequate hemodialysis therapy. Multiple reports have documented the type of vascular access used for dialysis and associated risk of infection and mortality. Undoubtedly, the central venous catheter (CVC) is associated with the greatest risk of infection-related and all-cause mortality compared with the autogenous arteriovenous fistula (AVF) or synthetic graft (AVG). The AVF has the lowest risk of infection, longer patency rates, greater quality of life, and lower all-cause mortality compared with the AVG or CVC. It is for these reasons that the National Kidney Foundation's Kidney Disease Outcome Quality Initiative Clinical Practice Guidelines for Vascular Access recommend the early placement and use of the AVF among at least 50% of incident hemodialysis patients. This report presents catheter-related mortality and calls for heightened awareness of catheter-related complications.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Continuous Renal Replacement Therapy
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...